The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is ANI Pharmaceuticals (ANIP) one of those stocks right now? A ...

Truist analyst Les Sulewski raised the firm’s price target on ANI Pharmaceuticals (ANIP) to $65 from $62 and keeps a Hold rating on the shares ...

ANI Pharmaceuticals stock opened at $68.12 on Friday. ANI Pharmaceuticals has a 52-week low of $52.50 and a 52-week high of $70.00. The company has a market cap of $1.48 billion, a price-to ...

During the last three months, 6 analysts shared their evaluations of ANI Pharmaceuticals ANIP, revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their ...

ANI Pharmaceuticals has a 12 month low of $52.50 and a 12 month high of $70.00. The stock has a market capitalization of $1.44 billion, a P/E ratio of -120.02 and a beta of 0.49.

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...

The Delhi HC refused to stay the takedown order against sections of the Wikipedia page on news agency ANI, during an appeal filed by the online encyclopaedia on April 8. However, the court agreed ...

It’s a banner year for Wisconsin-based Ani DiFranco fans. DiFranco did a live interview at Milwaukee’s Oriental Theater last October repping her documentary “1-800-On-Her-Own,” and she wil ...

Has ANI Pharmaceuticals (ANIP) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question ...

Has ANI Pharmaceuticals (ANIP) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that ...